文献速递功能神经外科

帕金森病苍白球深部脑刺激的临床结局:术中MRI与微电极记录引导电极放置的比较

Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement.
PubMed 文献 · J Neurosurg · 2020-03-06

该研究比较了帕金森病患者接受苍白球内段深部脑刺激时,术中MRI引导与微电极记录引导的电极放置准确度、安全性及运动结局。共纳入77例患者(微电极记录组28例,术中MRI组49例),放置131根电极。术中MRI引导的立体定向准确度更高,两组严重并发症发生率相似,术中MRI组UPDRS III运动评分改善更显著,左旋多巴等效日剂量减少程度相似。

要点

  • 术中MRI引导的电极放置立体定向准确度为0.84±0.007 mm,优于微电极记录引导的1.94±0.21 mm。
  • 两组严重并发症发生率相似,微电极记录组为6.9%,术中MRI组为9.4%。
  • 术中MRI组UPDRS III运动评分改善43.2%±3.5%,微电极记录组改善25.5%±6.7%。

核心结论

  • 术中MRI引导的苍白球内段深部脑刺激电极放置与临床结局显著改善相关,与微电极记录引导所观察到的结局相当,且安全性相似,可作为微电极记录引导的替代方案。

研究设计与样本

  • 研究为在埃默里大学开展的比较性研究,纳入2007年7月至2016年8月期间接受苍白球内段深部脑刺激电极放置的帕金森病患者,微电极记录组28例,术中MRI组49例,共放置131根电极。

主要发现

  • 电极放置的立体定向准确度:框架式微电极记录引导为1.94±0.21 mm(95%CI 1.54-2.34),术中MRI引导为0.84±0.007 mm(95%CI 0.69-0.98)。
  • 严重并发症发生率:微电极记录引导组为6.9%,术中MRI引导组为9.4%(RR 0.71,95%CI 0.13%-3.9%,p=0.695)。
  • 完成12个月随访的57例患者中,术中MRI组UPDRS III运动评分改善43.2%±3.5%(95%CI 36.2%-50.3%),微电极记录组改善25.5%±6.7%(95%CI 11.1%-39.8%),F=5.835,p=0.019。
  • 仅评估对侧半身UPDRS III运动评分时,微电极记录组改善37.1%±7.2%(95%CI 22.2%-51.9%),术中MRI组改善50.0%±3.5%(95%CI 43.1%-56.9%)。
  • 左旋多巴等效日剂量减少:微电极记录组减少21.2%,术中MRI组减少20.9%,F=0.221,p=0.640。

关键数值与推荐

  • 基线左旋多巴挑战反应:微电极记录组为44.8%±5.4%(95%CI 33.2%-56.4%),术中MRI组为61.6%±2.1%(95%CI 57.4%-65.8%),t=3.558,p=0.001。
  • 所有活性触点位置及与苍白球内段深部脑刺激共识坐标(x,±20;y,+2;z,-4)的二维径向距离在两种手术类型间无统计学差异。

临床怎么用

  • 对于接受苍白球内段深部脑刺激植入的帕金森病患者,术中MRI引导可作为微电极记录引导的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) lead placement is increasingly performed with the patient under general anesthesia by surgeons using intraoperative MRI (iMRI) guidance without microelectrode recording (MER) or macrostimulation. The authors assessed the accuracy of lead placement, safety, and motor outcomes in patients with Parkinson disease (PD) undergoing DBS lead placement into the globus pallidus internus (GPi) using iMRI or MER guidance. METHODS: The authors identified all patients with PD who underwent either MER- or iMRI-guided GPi-DBS lead placement at Emory University between July 2007 and August 2016. Lead placement accuracy and adverse events were determined for all patients. Clinical outcomes were assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) part III motor scores for patients completing 12 months of follow-up. The authors also assessed the levodopa-equivalent daily dose (LEDD) and stimulation parameters. RESULTS: Seventy-seven patients were identified (MER, n = 28; iMRI, n = 49), in whom 131 leads were placed. The stereotactic accuracy of the surgical procedure with respect to the planned lead location was 1.94 ± 0.21 mm (mean ± SEM) (95% CI 1.54-2.34) with frame-based MER and 0.84 ± 0.007 mm (95% CI 0.69-0.98) with iMRI. The rate of serious complications was similar, at 6.9% for MER-guided DBS lead placement and 9.4% for iMRI-guided DBS lead placement (RR 0.71 [95% CI 0.13%-3.9%]; p = 0.695). Fifty-seven patients were included in clinical outcome analyses (MER, n = 16; iMRI, n = 41). Both groups had similar characteristics at baseline, although patients undergoing MER-guided DBS had a lower response on their baseline levodopa challenge (44.8% ± 5.4% [95% CI 33.2%-56.4%] vs 61.6% ± 2.1% [95% CI 57.4%-65.8%]; t = 3.558, p = 0.001). Greater improvement was seen following iMRI-guided lead placement (43.2% ± 3.5% [95% CI 36.2%-50.3%]) versus MER-guided lead placement (25.5% ± 6.7% [95% CI 11.1%-39.8%]; F = 5.835, p = 0.019). When UPDRS III motor scores were assessed only in the contralateral hemibody (per-lead analyses), the improvements remained significantly different (37.1% ± 7.2% [95% CI 22.2%-51.9%] and 50.0% ± 3.5% [95% CI 43.1%-56.9%] for MER- and iMRI-guided DBS lead placement, respectively). Both groups exhibited similar reductions in LEDDs (21.2% and 20.9%, respectively; F = 0.221, p = 0.640). The locations of all active contacts and the 2D radial distance from these to consensus coordinates for GPi-DBS lead placement (x, ±20; y, +2; and z, -4) did not differ statistically by type of surgery. CONCLUSIONS: iMRI-guided GPi-DBS lead placement in PD patients was associated with significant improvement in clinical outcomes, comparable to those observed following MER-guided DBS lead placement. Furthermore, iMRI-guided DBS implantation produced a similar safety profile to that of the MER-guided procedure. As such, iMRI guidance is an alternative to MER guidance for patients undergoing GPi-DBS implantation for PD.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bezchlibnyk YB, Sharma VD, Naik KB, et al. Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement. J Neurosurg. 2020. PMID: 32114534. doi:10.3171/2019.12.JNS192010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。